好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Rapid Adaption of Telemedicine: A Neurology Division’s Perception of Effects on Care Delivery and Provider Wellness
Practice, Policy, and Ethics
Practice, Policy, and Ethics Posters (7:00 AM-5:00 PM)
023
To evaluate provider perceptions of telemedicine as an effective method of care delivery and to characterize its impact on provider wellness within a pediatric tertiary care center’s neurology division.
Assessing provider wellness has become increasingly relevant given that neurologists have the second highest burnout rate among all specialists.  Prior to the COVID-19 pandemic, the institution was building telemedicine infrastructure and tools to assess its effectiveness in care delivery and effects on provider wellness. In March 2020, the COVID-19 pandemic prompted an abrupt switch from in-person visits to exclusively telemedicine visits.  Because rapid deployment of telemedicine was critical to sustaining high quality patient care, determining feasibility, acceptability, and impact on provider wellness occurred in real time.
From March to July 2020, neurology providers that completed a telemedicine visit were sent periodic REDCap surveys to elicit feedback on technology feasibility and impact on patient care, work-life balance, and professional fulfillment. Provider data was de-identified and analyzed for trends for over time.
There were four cycles of survey collection with 102 responses. The majority of providers reported that telemedicine was an adequate alternative to in-person exams.  Technical issues were commonly reported, including communication interruptions (53%) and problematic video (61%) or audio (74%) quality. The reported frequency of problematic video and audio quality decreased from March to July (22% and 43% respectively). There was considerable reduction in provider commute. From March/April to June/July, providers reported improved professional fulfillment (32 % to 49%) and work life balance (51% to 77%) with telemedicine use. Nearly all providers (97%) would consider some form of telemedicine in the future despite the occurrence of technical difficulties.

Despite the rapid deployment of telemedicine, providers reported that it was a feasible and acceptable method of care delivery that may improve provider wellness.
Authors/Disclosures
Marissa P. DiGiovine, MD
PRESENTER 		The institution of Dr. DiGiovine has received research support from HRSA.
No disclosure on file
Lawrence E. Fried, MD (Children's Hospital of Philadelphia, Child Neurology) Dr. Fried has received personal compensation for serving as an employee of Bayer Pharmaceuticals. Dr. Fried has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Virpax Pharmaceuticals. Dr. Fried has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Fried has stock in Bayer. Dr. Fried has stock in Horus. The institution of Dr. Fried has received research support from Health Resources & Services Administration of the United States Department of Health and Human Services.
Laurel Caffee (The Children's Hospital of Philadelphia) Laurel Caffeé has nothing to disclose.
No disclosure on file
No disclosure on file
Bethany Thomas, NP (HUP) Ms. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Bioscience. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Ms. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Bioscience.
No disclosure on file